Guillaume Marquis-Gravel

Université de Montréal

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

John Alexander

Duke University

UNITED STATES

View details

Stephen E. Fremes

University of Toronto

CANADA

View details

Geoffrey H Tison

University of California, San Francisco

UNITED STATES

View details

Dominique Vervoort

University of Toronto

CANADA

View details

Bradley Hammill

Associate Professor

Duke University

UNITED STATES

View details

Jennifer Kraschnewski

Penn State College of Medicine

UNITED STATES

View details

Marie Lordkipanidze

Associate professor

CANADA

View details

Amanda Stebbins

Duke University

UNITED STATES

View details

Philippe Gabriel Steg

FRANCE

View details

Matthew Ryan

King's College London

UNITED KINGDOM

View details

Ruth Masterson Creber

Professor of Nursing

Columbia University

UNITED STATES

View details

Thomas J. Povsic

UNITED STATES

View details

Lisa Wruck

Duke University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Guillaume Marquis-Gravel

Research Interests

Explore related searches

Contact this professor

Articles (19)

Surgical Risk and Long-Term Mortality With PCI and CABG in Ischemic Left Ventricular Systolic Dysfunction

Adenosine Contrast Correlations in Evaluating Revascularization: The (ACCELERATION) Study

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease

Evaluation of stenoses using AI video models applied to coronary angiography

Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial

Left Atrial Appendix Occlusion During Structural Procedures: Keep It Simple!

Care Gaps and System Issues With Delivering Cardiovascular Risk Reduction and Lipid-Lowering Therapy in Secondary Prevention

Should Rotational Atherectomy Be Used More Often in STEMI to Treat Calcified Culprit Lesions?

The Interface Between Cardiac Surgery and Interventional Cardiology

Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention

STICH3C: Rationale and Study Protocol

Can we define the role of cardiac stress testing after percutaneous coronary intervention using observational data?

Aspirin for Primary Cardiovascular Prevention in Patients with Diabetes: Uncertainties and Opportunities

Importance of patient engagement in the conduct of pragmatic multicenter randomized controlled trials: The ADAPTABLE experience

Lipid lowering in primary prevention: time to focus on young patients

Forty Years of Innovations: The Past, Present, and Future of Interventional Cardiology

How Coronary Stents Became a Reality: A Firsthand Account by an Innovator in the Field

The Evolution of Antiplatelet Therapy After Percutaneous Coronary Interventions: A 40-Year Journey

The Ongoing Saga of the Evolution of Percutaneous Coronary Intervention: From Balloon Angioplasty to Recent Innovations to Future Prospects

Collaborators (13)

John Alexander

Stephen E. Fremes

Geoffrey H Tison

Dominique Vervoort

Bradley Hammill

Jennifer Kraschnewski

Marie Lordkipanidze

Amanda Stebbins

Philippe Gabriel Steg

Matthew Ryan

Ruth Masterson Creber

Thomas J. Povsic

Lisa Wruck

Make your next move.